Aspartame: Scientific Evaluation in the Postmarketing Period
Prior to marketing, the safety of the high-intensity sweetener aspartame for its intended uses as a sweetener and flavor enhancer was demonstrated by the results of over 100 scientific studies in animals and humans. In the postmarketing period, the safety of aspartame was further evaluated through e...
Gespeichert in:
Veröffentlicht in: | Regulatory toxicology and pharmacology 2001-12, Vol.34 (3), p.221-233 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 233 |
---|---|
container_issue | 3 |
container_start_page | 221 |
container_title | Regulatory toxicology and pharmacology |
container_volume | 34 |
creator | Butchko, Harriett H. Stargel, W.Wayne |
description | Prior to marketing, the safety of the high-intensity sweetener aspartame for its intended uses as a sweetener and flavor enhancer was demonstrated by the results of over 100 scientific studies in animals and humans. In the postmarketing period, the safety of aspartame was further evaluated through extensive monitoring of intake, postmarketing surveillance of anecdotal reports of alleged health effects, and additional research to evaluate these anecdotal reports and other scientific issues. The results of the extensive intake evaluation in the United States, which was done over an 8-year period, and the results of studies done in other countries demonstrated intakes which were well below the acceptable daily intakes set by the FDA and regulatory bodies in other countries, as well as the Joint FAO/WHO Expert Committee on Food Additives. Evaluation of the anecdotal reports of adverse health effects, the first such system for a food additive, revealed that the reported effects were generally mild and also common in the general population and that there was no consistent or unique pattern of symptoms that could be causally linked to consumption of aspartame. Finally, the results of the extensive scientific research done to evaluate these allegations did not show a causal relationship between aspartame and adverse effects. Thus, the weight of scientific evidence confirms that, even in amounts many times what people typically consume, aspartame is safe for its intended uses as a sweetener and flavor enhancer. |
doi_str_mv | 10.1006/rtph.2001.1500 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72385919</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0273230001915004</els_id><sourcerecordid>18224948</sourcerecordid><originalsourceid>FETCH-LOGICAL-c401t-649126666173f839f106ceee165c1a4397bed8c7dee4d9a97ca05eca3d2529d13</originalsourceid><addsrcrecordid>eNqF0DFP3DAUwHGroioH7dqxygJbjvfsOI4Ry-lEKRJSkWhny9gvYJpLDttB4ts36Z3EhOrFy-892X_GviIsEaA-i3n7uOQAuEQJ8IEtEHRdAtfygC2AK1FyAXDIjlJ6AgDeNOoTO0RUspJcLdjFKm1tzHZD58WdC9Tn0AZXXL7YbrQ5DH0R-iI_UnE7pLyx8Q_l0D8UtxTD4D-zj63tEn3Z38fs9_fLX-sf5c3Pq-v16qZ0FWAu60ojr6eDSrSN0C1C7YgIa-nQVkKre_KNU56o8tpq5SxIclZ4Lrn2KI7Z6W7vNg7PI6VsNiE56jrb0zAmo7hopEb9X4gN55Wumgkud9DFIaVIrdnGMH3v1SCYOayZw5o5rJnDTgPf9pvH-w35N74vOYGTPbDJ2a6NtnchvTlRScB_rtk5moK9BIomzdkd-RDJZeOH8N4b_gIBK5M9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18224948</pqid></control><display><type>article</type><title>Aspartame: Scientific Evaluation in the Postmarketing Period</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Butchko, Harriett H. ; Stargel, W.Wayne</creator><creatorcontrib>Butchko, Harriett H. ; Stargel, W.Wayne</creatorcontrib><description>Prior to marketing, the safety of the high-intensity sweetener aspartame for its intended uses as a sweetener and flavor enhancer was demonstrated by the results of over 100 scientific studies in animals and humans. In the postmarketing period, the safety of aspartame was further evaluated through extensive monitoring of intake, postmarketing surveillance of anecdotal reports of alleged health effects, and additional research to evaluate these anecdotal reports and other scientific issues. The results of the extensive intake evaluation in the United States, which was done over an 8-year period, and the results of studies done in other countries demonstrated intakes which were well below the acceptable daily intakes set by the FDA and regulatory bodies in other countries, as well as the Joint FAO/WHO Expert Committee on Food Additives. Evaluation of the anecdotal reports of adverse health effects, the first such system for a food additive, revealed that the reported effects were generally mild and also common in the general population and that there was no consistent or unique pattern of symptoms that could be causally linked to consumption of aspartame. Finally, the results of the extensive scientific research done to evaluate these allegations did not show a causal relationship between aspartame and adverse effects. Thus, the weight of scientific evidence confirms that, even in amounts many times what people typically consume, aspartame is safe for its intended uses as a sweetener and flavor enhancer.</description><identifier>ISSN: 0273-2300</identifier><identifier>EISSN: 1096-0295</identifier><identifier>DOI: 10.1006/rtph.2001.1500</identifier><identifier>PMID: 11754527</identifier><identifier>CODEN: RTOPDW</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Animals ; aspartame ; Aspartame - administration & dosage ; Aspartame - adverse effects ; Aspartame - chemistry ; Australia ; Biological and medical sciences ; Brazil ; Centers for Disease Control and Prevention (U.S.) - statistics & numerical data ; Europe ; food additives ; Food Industry - statistics & numerical data ; Food toxicology ; Humans ; Medical sciences ; Nutrition Policy ; Product Surveillance, Postmarketing - standards ; Product Surveillance, Postmarketing - statistics & numerical data ; sweeteners ; Toxicology ; United States ; United States Food and Drug Administration - statistics & numerical data</subject><ispartof>Regulatory toxicology and pharmacology, 2001-12, Vol.34 (3), p.221-233</ispartof><rights>2001 Elsevier Science (USA)</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c401t-649126666173f839f106ceee165c1a4397bed8c7dee4d9a97ca05eca3d2529d13</citedby><cites>FETCH-LOGICAL-c401t-649126666173f839f106ceee165c1a4397bed8c7dee4d9a97ca05eca3d2529d13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/rtph.2001.1500$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13450127$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11754527$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Butchko, Harriett H.</creatorcontrib><creatorcontrib>Stargel, W.Wayne</creatorcontrib><title>Aspartame: Scientific Evaluation in the Postmarketing Period</title><title>Regulatory toxicology and pharmacology</title><addtitle>Regul Toxicol Pharmacol</addtitle><description>Prior to marketing, the safety of the high-intensity sweetener aspartame for its intended uses as a sweetener and flavor enhancer was demonstrated by the results of over 100 scientific studies in animals and humans. In the postmarketing period, the safety of aspartame was further evaluated through extensive monitoring of intake, postmarketing surveillance of anecdotal reports of alleged health effects, and additional research to evaluate these anecdotal reports and other scientific issues. The results of the extensive intake evaluation in the United States, which was done over an 8-year period, and the results of studies done in other countries demonstrated intakes which were well below the acceptable daily intakes set by the FDA and regulatory bodies in other countries, as well as the Joint FAO/WHO Expert Committee on Food Additives. Evaluation of the anecdotal reports of adverse health effects, the first such system for a food additive, revealed that the reported effects were generally mild and also common in the general population and that there was no consistent or unique pattern of symptoms that could be causally linked to consumption of aspartame. Finally, the results of the extensive scientific research done to evaluate these allegations did not show a causal relationship between aspartame and adverse effects. Thus, the weight of scientific evidence confirms that, even in amounts many times what people typically consume, aspartame is safe for its intended uses as a sweetener and flavor enhancer.</description><subject>Animals</subject><subject>aspartame</subject><subject>Aspartame - administration & dosage</subject><subject>Aspartame - adverse effects</subject><subject>Aspartame - chemistry</subject><subject>Australia</subject><subject>Biological and medical sciences</subject><subject>Brazil</subject><subject>Centers for Disease Control and Prevention (U.S.) - statistics & numerical data</subject><subject>Europe</subject><subject>food additives</subject><subject>Food Industry - statistics & numerical data</subject><subject>Food toxicology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Nutrition Policy</subject><subject>Product Surveillance, Postmarketing - standards</subject><subject>Product Surveillance, Postmarketing - statistics & numerical data</subject><subject>sweeteners</subject><subject>Toxicology</subject><subject>United States</subject><subject>United States Food and Drug Administration - statistics & numerical data</subject><issn>0273-2300</issn><issn>1096-0295</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0DFP3DAUwHGroioH7dqxygJbjvfsOI4Ry-lEKRJSkWhny9gvYJpLDttB4ts36Z3EhOrFy-892X_GviIsEaA-i3n7uOQAuEQJ8IEtEHRdAtfygC2AK1FyAXDIjlJ6AgDeNOoTO0RUspJcLdjFKm1tzHZD58WdC9Tn0AZXXL7YbrQ5DH0R-iI_UnE7pLyx8Q_l0D8UtxTD4D-zj63tEn3Z38fs9_fLX-sf5c3Pq-v16qZ0FWAu60ojr6eDSrSN0C1C7YgIa-nQVkKre_KNU56o8tpq5SxIclZ4Lrn2KI7Z6W7vNg7PI6VsNiE56jrb0zAmo7hopEb9X4gN55Wumgkud9DFIaVIrdnGMH3v1SCYOayZw5o5rJnDTgPf9pvH-w35N74vOYGTPbDJ2a6NtnchvTlRScB_rtk5moK9BIomzdkd-RDJZeOH8N4b_gIBK5M9</recordid><startdate>20011201</startdate><enddate>20011201</enddate><creator>Butchko, Harriett H.</creator><creator>Stargel, W.Wayne</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7U1</scope><scope>7U2</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20011201</creationdate><title>Aspartame: Scientific Evaluation in the Postmarketing Period</title><author>Butchko, Harriett H. ; Stargel, W.Wayne</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c401t-649126666173f839f106ceee165c1a4397bed8c7dee4d9a97ca05eca3d2529d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Animals</topic><topic>aspartame</topic><topic>Aspartame - administration & dosage</topic><topic>Aspartame - adverse effects</topic><topic>Aspartame - chemistry</topic><topic>Australia</topic><topic>Biological and medical sciences</topic><topic>Brazil</topic><topic>Centers for Disease Control and Prevention (U.S.) - statistics & numerical data</topic><topic>Europe</topic><topic>food additives</topic><topic>Food Industry - statistics & numerical data</topic><topic>Food toxicology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Nutrition Policy</topic><topic>Product Surveillance, Postmarketing - standards</topic><topic>Product Surveillance, Postmarketing - statistics & numerical data</topic><topic>sweeteners</topic><topic>Toxicology</topic><topic>United States</topic><topic>United States Food and Drug Administration - statistics & numerical data</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Butchko, Harriett H.</creatorcontrib><creatorcontrib>Stargel, W.Wayne</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Regulatory toxicology and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Butchko, Harriett H.</au><au>Stargel, W.Wayne</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Aspartame: Scientific Evaluation in the Postmarketing Period</atitle><jtitle>Regulatory toxicology and pharmacology</jtitle><addtitle>Regul Toxicol Pharmacol</addtitle><date>2001-12-01</date><risdate>2001</risdate><volume>34</volume><issue>3</issue><spage>221</spage><epage>233</epage><pages>221-233</pages><issn>0273-2300</issn><eissn>1096-0295</eissn><coden>RTOPDW</coden><abstract>Prior to marketing, the safety of the high-intensity sweetener aspartame for its intended uses as a sweetener and flavor enhancer was demonstrated by the results of over 100 scientific studies in animals and humans. In the postmarketing period, the safety of aspartame was further evaluated through extensive monitoring of intake, postmarketing surveillance of anecdotal reports of alleged health effects, and additional research to evaluate these anecdotal reports and other scientific issues. The results of the extensive intake evaluation in the United States, which was done over an 8-year period, and the results of studies done in other countries demonstrated intakes which were well below the acceptable daily intakes set by the FDA and regulatory bodies in other countries, as well as the Joint FAO/WHO Expert Committee on Food Additives. Evaluation of the anecdotal reports of adverse health effects, the first such system for a food additive, revealed that the reported effects were generally mild and also common in the general population and that there was no consistent or unique pattern of symptoms that could be causally linked to consumption of aspartame. Finally, the results of the extensive scientific research done to evaluate these allegations did not show a causal relationship between aspartame and adverse effects. Thus, the weight of scientific evidence confirms that, even in amounts many times what people typically consume, aspartame is safe for its intended uses as a sweetener and flavor enhancer.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>11754527</pmid><doi>10.1006/rtph.2001.1500</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0273-2300 |
ispartof | Regulatory toxicology and pharmacology, 2001-12, Vol.34 (3), p.221-233 |
issn | 0273-2300 1096-0295 |
language | eng |
recordid | cdi_proquest_miscellaneous_72385919 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Animals aspartame Aspartame - administration & dosage Aspartame - adverse effects Aspartame - chemistry Australia Biological and medical sciences Brazil Centers for Disease Control and Prevention (U.S.) - statistics & numerical data Europe food additives Food Industry - statistics & numerical data Food toxicology Humans Medical sciences Nutrition Policy Product Surveillance, Postmarketing - standards Product Surveillance, Postmarketing - statistics & numerical data sweeteners Toxicology United States United States Food and Drug Administration - statistics & numerical data |
title | Aspartame: Scientific Evaluation in the Postmarketing Period |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T05%3A48%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Aspartame:%20Scientific%20Evaluation%20in%20the%20Postmarketing%20Period&rft.jtitle=Regulatory%20toxicology%20and%20pharmacology&rft.au=Butchko,%20Harriett%20H.&rft.date=2001-12-01&rft.volume=34&rft.issue=3&rft.spage=221&rft.epage=233&rft.pages=221-233&rft.issn=0273-2300&rft.eissn=1096-0295&rft.coden=RTOPDW&rft_id=info:doi/10.1006/rtph.2001.1500&rft_dat=%3Cproquest_cross%3E18224948%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18224948&rft_id=info:pmid/11754527&rft_els_id=S0273230001915004&rfr_iscdi=true |